Nyctea

Nyctea Technologies is a biotechnology company based in Göteborg, Sweden, founded in 2020 by Gustav Ferrand-Drake del Castillo and Andreas Dahlin. The company specializes in innovative purification processes for biopharmaceutical production, focusing on electrode-based filtration technology. This technology captures and releases biopharmaceuticals using electronic signals, offering a more efficient alternative to traditional chromatography methods.

The electrode filter developed by Nyctea Technologies enhances the purification of proteins, antibodies, gene vectors, and vaccines. It aims to reduce production costs and time while increasing yield and control. The company is also exploring applications in drug delivery devices, such as controlled-release tablets. With a commitment to environmental sustainability, Nyctea Technologies is working towards creating automated systems for biomedical production and diagnostics. The company has filed a patent related to its technology and has secured $40K in seed funding.